QIAGEN Clinical Insight Interpret Earns IVDR Certification for Oncology and Hereditary Applications

As the first NGS interpretation platform for both oncology and hereditary applications, the updated version of QIAGEN Clinical Insight Interpret is appro...

May 16, 2024 | Thursday | News
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity

Genentech, a member of the Roche Group  announced positive results from the Phase Ib clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being...

May 16, 2024 | Thursday | News
Thermo Fisher Debuts Array for Advanced Blood Typing, Aiding Safer Transfusions

Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Applied Biosystems™ Axiom™ BloodGenomiX™ Array* a...

May 15, 2024 | Wednesday | News
Atraverse Medical's HOTWIRE™ RF Guidewire Receives FDA Clearance, Revolutionizing Left-Heart Access

Atraverse Medical, a San Diego-based medical device company, announces the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel devic...

May 15, 2024 | Wednesday | News
BenevolentAI & AstraZeneca Unveil Novel Heart Failure Target

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma ...

May 15, 2024 | Wednesday | News
Baxter’s Clinolipid Receives U.S. FDA Approval for Pediatric Use, Expanding Access to Vital Nutrition Therapy

Baxter International Inc. (NYSE: BAX), a pioneer in nutrition therapy, proudly announces the United States Food and Drug Administration (FDA) approval of a...

May 14, 2024 | Tuesday | News
Photocure's Partner Asieris Pharmaceuticals Advances Cevira® for Potential Approval in China

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National...

May 13, 2024 | Monday | News
ArcScan's Insight® 100 Granted NMPA Approval in China, Offering Advanced Solution for Myopia Treatment

ArcScan, Inc., a global medical technology company dedicated to helping ophthalmologists improve vision with ultra-high frequency ultrasound diagnostic ima...

May 13, 2024 | Monday | News
Zai Lab's AUGTYRO™ Approved by NMPA in China for ROS1-Positive NSCLC Treatment

Zai Lab Limited announced that the National Medical Products Administration (NMPA) in China has approved the New Drug Application (NDA) for AUGTYRO™ ...

May 13, 2024 | Monday | News
MSD Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

  Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global materna...

May 09, 2024 | Thursday | News
Bio-Rad's CEO, Norman Schwartz, Finds Hope in Adversity: "Our Vision Remains Strong Despite Market Challenges"

  First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compared to $676.8 million reported for the first quarter of 2023...

May 08, 2024 | Wednesday | Company results
BrioHealth Solutions Granted FDA Approval to Commence Landmark Trial for Novel Heart Failure Treatment

BrioHealth Solutions, Inc., a medical technology company focused on developing innovative advanced heart failure solutions, announced it has received FDA I...

May 02, 2024 | Thursday | News
Johnson & Johnson Unifies Business Segments, Enhancing Healthcare Solutions in the UK

Johnson & Johnson announced it is updating its brand and uniting both its two business segments under the Johnson & Johnson brand name in the UK. ...

May 01, 2024 | Wednesday | News
SS Innovations' SSi Mantra System Completes First Infant Pyeloplasty in India

SS Innovations International, Inc., a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible t...

April 30, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close